Catalyst Wire Dossier Catalyst Wire Dossier

SGN-ALPV

· Seagen Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGN-ALPV, covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]

See pricing